Key Benefits

• A highly effective, Extended spectrum antibiotic, covers Gram positive, Gram negative & anaerobic pathogens
  
  
• Effective against b-lactamase producing organisms like S. pneumoniae, H. influenzae, M. catarrhalis
  
  
• Stable against b-lactamase & PBP mediated resistance
  
  
• Highest MEF concentration than many Cephalosporins
  
  
• Offers Clinical & Bacteriological cure
  
  
• Well tolerated, proven safety

Indications

• Benzoclav oral presentations for twice daily dosing are indicated for short term treatment of bacterial infection at the following sites:
  
  
• Upper respiratory tract infections (including ENT) e.g. recurrent tonsillitis, sinusitis, otitis media.
  
  
• Lower respiratory tract infections e.g. exacerbation of chronic bronchitis, lobar and bronchopneumonia.
  
  
• Urinary tract infections e.g. cystitis, urethritis, pyelonephritis.
  
  
• Skin and soft tissue infections e.g. cellulites, animal bites, boils, abscesses, wound infections.
  
  
• Bone and joint infections e.g. osteomyelitis.
  
  
• Dental infections e.g. severe dental abscess with spreading cellulitis.
  
  
• Other infection e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis